Borregaard ASA (BRG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Borregaard ASA (BRG) has a cash flow conversion efficiency ratio of 0.071x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr419.00 Million) by net assets (Nkr5.88 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Borregaard ASA - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Borregaard ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Borregaard ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Borregaard ASA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Urban Transport Planning Center Co. Ltd.
SHE:301091
|
N/A |
|
Borusan Mannesmann Boru Sanayi ve Ticaret AS
IS:BRSAN
|
0.011x |
|
LendingClub Corp
NYSE:LC
|
-1.817x |
|
Visual Photonics Epitaxy Co Ltd
TW:2455
|
0.080x |
|
SJW Group Common Stock
NYSE:SJW
|
0.031x |
|
Bursa Malaysia Bhd
KLSE:1818
|
0.108x |
|
Beijing Bei Mo Gao Ke Friction Mate
SHE:002985
|
0.033x |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
0.009x |
Annual Cash Flow Conversion Efficiency for Borregaard ASA (2009–2025)
The table below shows the annual cash flow conversion efficiency of Borregaard ASA from 2009 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr5.88 Billion | Nkr1.36 Billion | 0.231x | +9.95% |
| 2024-12-31 | Nkr5.09 Billion | Nkr1.07 Billion | 0.210x | -34.30% |
| 2023-12-31 | Nkr4.89 Billion | Nkr1.56 Billion | 0.319x | +93.14% |
| 2022-12-31 | Nkr4.45 Billion | Nkr735.00 Million | 0.165x | -50.24% |
| 2021-12-31 | Nkr4.31 Billion | Nkr1.43 Billion | 0.332x | +41.71% |
| 2020-12-31 | Nkr3.78 Billion | Nkr886.00 Million | 0.235x | +16.55% |
| 2019-12-31 | Nkr3.46 Billion | Nkr697.00 Million | 0.201x | +19.75% |
| 2018-12-31 | Nkr3.32 Billion | Nkr558.00 Million | 0.168x | -35.46% |
| 2017-12-31 | Nkr3.00 Billion | Nkr780.00 Million | 0.260x | -34.66% |
| 2016-12-31 | Nkr2.71 Billion | Nkr1.08 Billion | 0.398x | +45.86% |
| 2015-12-31 | Nkr2.06 Billion | Nkr563.00 Million | 0.273x | -11.27% |
| 2014-12-31 | Nkr1.95 Billion | Nkr600.00 Million | 0.308x | +5.81% |
| 2013-12-31 | Nkr1.86 Billion | Nkr540.00 Million | 0.291x | -8.28% |
| 2012-12-31 | Nkr1.74 Billion | Nkr551.00 Million | 0.317x | -33.54% |
| 2011-12-31 | Nkr1.12 Billion | Nkr536.00 Million | 0.477x | +7.07% |
| 2010-12-31 | Nkr1.01 Billion | Nkr452.00 Million | 0.446x | +19.84% |
| 2009-12-31 | Nkr1.35 Billion | Nkr504.00 Million | 0.372x | -- |
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construct… Read more